Baron Health Care Retail (BHCFX)
17.47
+0.19 (+1.10%)
USD |
Jul 01 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.10% | 196.17M | 0.00% | 55.38% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 65.83M | -16.40% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. Under normal circumstances, the fund invests at least 80% of its net assets in equity securities in the form of common stock of companies engaged in the research, development, production, sale, delivery or distribution of products and services related to the health care industry. The Adviser uses various criteria to determine whether an issuer is engaged in activities related to the health care industry. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | BHCHX |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Baron Capital Group, Inc. |
| Prospectus Benchmark Index | |
| Russell 3000 Ind/HC TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Neal Kaufman | 4.09 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
9
65.83M
-3.341B
Category Low
9.417B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of June 30, 2022
Performance Versus Category
As of July 01, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of July 01, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 8.55% | 505.12 | -2.37% |
| Thermo Fisher Scientific Inc | 5.20% | 544.67 | -0.66% |
| Bio-Techne Corp | 5.19% | 362.40 | 2.61% |
| Eli Lilly and Co | 4.27% | 327.08 | 0.73% |
| AstraZeneca PLC ADR | 3.89% | 65.52 | -0.64% |
|
Dechra Pharmaceuticals PLC
|
3.32% | -- | -- |
| McKesson Corp | 2.80% | 322.22 | -2.22% |
| argenx SE ADR | 2.77% | 382.32 | 1.38% |
| Edwards Lifesciences Corp | 2.60% | 97.97 | 0.60% |
| Icon PLC | 2.57% | 216.31 | 1.69% |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. Under normal circumstances, the fund invests at least 80% of its net assets in equity securities in the form of common stock of companies engaged in the research, development, production, sale, delivery or distribution of products and services related to the health care industry. The Adviser uses various criteria to determine whether an issuer is engaged in activities related to the health care industry. It is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | BHCHX |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Baron Capital Group, Inc. |
| Prospectus Benchmark Index | |
| Russell 3000 Ind/HC TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Neal Kaufman | 4.09 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (7-1-22) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 34.66 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 4/30/2018 |
| Last Annual Report Date | 12/31/2021 |
| Last Prospectus Date | 12/31/2021 |
| Share Classes | |
| BHCHX | Inst |
| BHCUX | Retirement |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |